Table 3. Permutation-based repeated measures ANCOVA results for each of the six phyla/subphyla bacterial categories (Clade).
Category/Clade | ACTINOBACTERIA | R2 | P value | FDR |
Main effects | Disease phenotype | 0.126 | 0.001 | 0.01 |
Steroids | 0.021 | 0.029 | 0.08 | |
Interactions | Age of Surgery * ATG16L1 | 0.041 | 0.014 | 0.07 |
Measurements | 0.001 | 0.328 | 0.47 | |
Category/Clade | BACTEROIDETES | R2 | P value | FDR |
Main effects | Disease phenotype | 0.117 | 0.001 | 0.01 |
Smoking | 0.018 | 0.034 | 0.09 | |
5-ASA | 0.021 | 0.025 | 0.08 | |
Steroids | 0.023 | 0.013 | 0.07 | |
Interactions | Steroids * Immunomodulators | 0.040 | 0.006 | 0.04 |
Disease phenotype * 5-ASA | 0.019 | 0.023 | 0.08 | |
5-ASA * Age | 0.016 | 0.050 | 0.12 | |
5-ASA * C. difficile | 0.019 | 0.023 | 0.08 | |
Measurements | 0.002 | 0.047 | 0.12 | |
Category/Clade | FIRM.CLOSTRIDIUM GROUPIV | R2 | P value | FDR |
Main effects | Disease phenotype | 0.161 | 0.001 | 0.01 |
Gender | 0.038 | 0.003 | 0.02 | |
Smoking | 0.025 | 0.015 | 0.07 | |
NOD2 | 0.021 | 0.027 | 0.08 | |
Interactions | Disease phenotype * Age | 0.040 | 0.003 | 0.02 |
BMI * 5-ASA | 0.025 | 0.010 | 0.06 | |
Measurements | 0.008 | 0.001 | 0.01 | |
Category/Clade | FIRM.CLOSTRIDIUM GROUPXIVa | R2 | P value | FDR |
Main effects | Gender | 0.023 | 0.019 | 0.08 |
Interactions | Disease phenotype * Age | 0.049 | 0.004 | 0.03 |
Steroids * BMI | 0.030 | 0.011 | 0.06 | |
Measurements | 0.006 | 0.006 | 0.04 | |
Category/Clade | FIRM.BACILLUS | R2 | P value | FDR |
Main effects | Disease phenotype | 0.175 | 0.001 | 0.01 |
NOD2 | 0.016 | 0.046 | 0.12 | |
Interactions | Disease phenotype * Steroids | 0.040 | 0.002 | 0.02 |
Disease phenotype * Age | 0.027 | 0.032 | 0.09 | |
5-ASA * ATG16L1 | 0.025 | 0.025 | 0.08 | |
Steroids * Immunomodulators | 0.019 | 0.027 | 0.08 | |
Measurements | 0.008 | 0.001 | 0.01 | |
Category/Clade | PROTEOBACTERIA | R2 | P value | FDR |
Main effects | NOD2 | 0.027 | 0.016 | 0.07 |
Interactions | Steroids * NOD2 | 0.040 | 0.002 | 0.02 |
5-ASA * Race | 0.032 | 0.007 | 0.04 | |
Steroids * Immunomodulators | 0.021 | 0.030 | 0.08 | |
NOD2 * ATG16L1 | 0.056 | 0.019 | 0.08 | |
Measurements | 0.040 | 0.001 | 0.01 |
Sequencing results for all three platforms were available for 157 samples (44 ileal CD, 53 colitis and 60 control non-IBD). The variables and first order interactions with P≤0.05 are listed above. To address multiple comparison issues, the Benjamini-Hochberg method was applied to adjust P-values to the false discovery rate (FDR). The variables and first order interactions with FDR ≤0.05 are bolded.